{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:11:47Z","timestamp":1790939507548,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,2,20]],"date-time":"2008-02-20T00:00:00Z","timestamp":1203465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1038\/npp.2008.8","type":"journal-article","created":{"date-parts":[[2008,2,20]],"date-time":"2008-02-20T15:31:15Z","timestamp":1203521475000},"page":"2878-2887","source":"Crossref","is-referenced-by-count":42,"title":["Disruption of the CRF2 Receptor Pathway Decreases the Somatic Expression of Opiate Withdrawal"],"prefix":"10.1038","volume":"33","author":[{"given":"Francesco","family":"Papaleo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Ghozland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Ingallinesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Contarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,20]]},"reference":[{"key":"BFnpp20088_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1037\/0033-295X.111.1.33","volume":"111","author":"TB Baker","year":"2004","unstructured":"Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC (2004). Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 111: 33\u201351.","journal-title":"Psychol Rev"},{"key":"BFnpp20088_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/74263","volume":"24","author":"TL Bale","year":"2000","unstructured":"Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE et al (2000). Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24: 410\u2013414.","journal-title":"Nat Genet"},{"key":"BFnpp20088_CR3","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1523\/JNEUROSCI.23-12-05295.2003","volume":"23","author":"TL Bale","year":"2003","unstructured":"Bale TL, Vale WW (2003). Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J Neurosci 23: 5295\u20135301.","journal-title":"J Neurosci"},{"key":"BFnpp20088_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","volume":"44","author":"TL Bale","year":"2004","unstructured":"Bale TL, Vale WW (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525\u2013557.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFnpp20088_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s002130050983","volume":"144","author":"MR Carrera","year":"1999","unstructured":"Carrera MR, Schulteis G, Koob GF (1999). Heroin self-administration in dependent Wistar rats: increased sensitivity to naloxone. Psychopharmacology (Berl) 144: 111\u2013120.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp20088_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0091-3057(02)00740-2","volume":"72","author":"TJ Cicero","year":"2002","unstructured":"Cicero TJ, Nock B, Meyer ER (2002). Gender-linked differences in the expression of physical dependence in the rat. Pharmacol Biochem Behav 72: 691\u2013697.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp20088_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(98)01158-5","volume":"835","author":"A Contarino","year":"1999","unstructured":"Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale W et al (1999). Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Res 835: 1\u20139.","journal-title":"Brain Res"},{"key":"BFnpp20088_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1054\/npep.2002.0899","volume":"36","author":"A Contarino","year":"2002","unstructured":"Contarino A, Gold LH (2002). Targeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior. Neuropeptides 36: 103\u2013116.","journal-title":"Neuropeptides"},{"key":"BFnpp20088_CR9","doi-asserted-by":"publisher","first-page":"18649","DOI":"10.1073\/pnas.0506999102","volume":"102","author":"A Contarino","year":"2005","unstructured":"Contarino A, Papaleo F (2005). The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. Proc Natl Acad Sci USA 102: 18649\u201318654.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp20088_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1601-183X.2005.00142.x","volume":"5","author":"SC Coste","year":"2006","unstructured":"Coste SC, Heard AD, Phillips TJ, Stenzel-Poore MP (2006). Corticotropin-releasing factor receptor type 2-deficient mice display impaired coping behaviors during stress. Genes Brain Behav 5: 131\u2013138.","journal-title":"Genes Brain Behav"},{"key":"BFnpp20088_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/74255","volume":"24","author":"SC Coste","year":"2000","unstructured":"Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH et al (2000). Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 24: 403\u2013409.","journal-title":"Nat Genet"},{"key":"BFnpp20088_CR12","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1523\/JNEUROSCI.18-14-05529.1998","volume":"18","author":"S Erb","year":"1998","unstructured":"Erb S, Shaham Y, Stewart J (1998). The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 18: 5529\u20135536.","journal-title":"J Neurosci"},{"key":"BFnpp20088_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.biopsych.2006.03.063","volume":"61","author":"CK Funk","year":"2007","unstructured":"Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF (2007). Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 61: 78\u201386.","journal-title":"Biol Psychiatry"},{"key":"BFnpp20088_CR14","first-page":"536","volume":"205","author":"VF Gellert","year":"1978","unstructured":"Gellert VF, Holtzman SG (1978). Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther 205: 536\u2013546.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp20088_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1517\/14656566.5.4.713","volume":"5","author":"G Gonzalez","year":"2004","unstructured":"Gonzalez G, Oliveto A, Kosten TR (2004). Combating opiate dependence: a comparison among the available pharmacological options. Expert Opin Pharmacother 5: 713\u2013725.","journal-title":"Expert Opin Pharmacother"},{"key":"BFnpp20088_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1124\/jpet.301.1.333","volume":"301","author":"G Griebel","year":"2002","unstructured":"Griebel G, Simiand J, Steinberg R, Jung M, Gully D, Roger P et al (2002). 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders. J Pharmacol Exp Ther 301: 333\u2013345.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp20088_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1124\/pr.55.1.3","volume":"55","author":"RL Hauger","year":"2003","unstructured":"Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM (2003). International union of pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev 55: 21\u201326.","journal-title":"Pharmacol Rev"},{"key":"BFnpp20088_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.npp.1380104","volume":"11","author":"SC Heinrichs","year":"1994","unstructured":"Heinrichs SC, Menzaghi F, Pich EM, Baldwin HA, Rassnick S, Britton KT et al (1994). Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology 11: 179\u2013186.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp20088_CR19","doi-asserted-by":"publisher","first-page":"9142","DOI":"10.1523\/JNEUROSCI.1494-06.2006","volume":"26","author":"B Henry","year":"2006","unstructured":"Henry B, Vale W, Markou A (2006). The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress. J Neurosci 26: 9142\u20139152.","journal-title":"J Neurosci"},{"key":"BFnpp20088_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0169-328X(01)00050-X","volume":"89","author":"SP Ho","year":"2001","unstructured":"Ho SP, Takahashi LK, Livanov V, Spencer K, Lesher T, Maciag C et al (2001). Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor. Brain Res Mol Brain Res 89: 29\u201340.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFnpp20088_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.pbb.2006.12.021","volume":"86","author":"RA Hodgson","year":"2007","unstructured":"Hodgson RA, Higgins GA, Guthrie DH, Lu SX, Pond AJ, Mullins DE et al (2007). Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression. Pharmacol Biochem Behav 86: 431\u2013440.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp20088_CR22","doi-asserted-by":"publisher","first-page":"9414","DOI":"10.1523\/JNEUROSCI.1641-04.2004","volume":"24","author":"H Houshyar","year":"2004","unstructured":"Houshyar H, Manalo S, Dallman MF (2004). Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment. J Neurosci 24: 9414\u20139424.","journal-title":"J Neurosci"},{"key":"BFnpp20088_CR23","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1523\/JNEUROSCI.0740-06.2006","volume":"26","author":"PJ Kenny","year":"2006","unstructured":"Kenny PJ, Chen SA, Kitamura O, Markou A, Koob GF (2006). Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci 26: 5894\u20135900.","journal-title":"J Neurosci"},{"key":"BFnpp20088_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/74271","volume":"24","author":"T Kishimoto","year":"2000","unstructured":"Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F et al (2000). Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 24: 415\u2013419.","journal-title":"Nat Genet"},{"key":"BFnpp20088_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrd897","volume":"1","author":"MJ Kreek","year":"2002","unstructured":"Kreek MJ, LaForge KS, Butelman E (2002). Pharmacotherapy of addictions. Nat Rev Drug Discov 1: 710\u2013726.","journal-title":"Nat Rev Drug Discov"},{"key":"BFnpp20088_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00426773","volume":"54","author":"MA Linseman","year":"1977","unstructured":"Linseman MA (1977). Naloxone-precipitated withdrawal as a function of the morphine\u2013naloxone interval. Psychopharmacology (Berl) 54: 159\u2013164.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp20088_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00213-005-2207-5","volume":"181","author":"L Lu","year":"2005","unstructured":"Lu L, Chen H, Su W, Ge X, Yue W, Su F et al (2005). Role of withdrawal in reinstatement of morphine-conditioned place preference. Psychopharmacology (Berl) 181: 90\u2013100.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp20088_CR28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/383819a0","volume":"383","author":"HW Matthes","year":"1996","unstructured":"Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I et al (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383: 819\u2013823.","journal-title":"Nature"},{"key":"BFnpp20088_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0091-3057(79)90204-1","volume":"10","author":"RF Mucha","year":"1979","unstructured":"Mucha RF, Kalant H, Linseman MA (1979). Quantitative relationships among measures of morphine tolerance and physical dependence in the rat. Pharmacol Biochem Behav 10: 397\u2013405.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp20088_CR30","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/nn1123","volume":"6","author":"MB Muller","year":"2003","unstructured":"Muller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P et al (2003). Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 6: 1100\u20131107.","journal-title":"Nat Neurosci"},{"key":"BFnpp20088_CR31","unstructured":"NIDA (2005). Monitoring the future: national results on adolescent drug use. Available at http:\/\/www.monitoringthefuture.org . Accessed May 2007."},{"key":"BFnpp20088_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejphar.2004.07.091","volume":"499","author":"DM Nielsen","year":"2004","unstructured":"Nielsen DM, Carey GJ, Gold LH (2004). Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice. Eur J Pharmacol 499: 135\u2013146.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp20088_CR33","first-page":"557","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"CP O'Brien","year":"1996","unstructured":"O'Brien CP (1996). Drug addiction and drug abuse. In: Hardman JG, Limbird LE (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill: New York. pp 557\u2013577."},{"key":"BFnpp20088_CR34","unstructured":"OEDT (2006). European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2006. Available at http:\/\/www.emcdda.europa.eu . Accessed May 2007."},{"key":"BFnpp20088_CR35","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(24)38220-5","volume":"289","author":"S Okuyama","year":"1999","unstructured":"Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Nakazato A et al (1999). Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. J Pharmacol Exp Ther 289: 926\u2013935.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp20088_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbr.2006.02.009","volume":"170","author":"F Papaleo","year":"2006","unstructured":"Papaleo F, Contarino A (2006). Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice. Behav Brain Res 170: 110\u2013118.","journal-title":"Behav Brain Res"},{"key":"BFnpp20088_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.neuron.2007.01.022","volume":"53","author":"F Papaleo","year":"2007","unstructured":"Papaleo F, Kitchener P, Contarino A (2007). Disruption of the CRF\/CRF(1) receptor stress system exacerbates the somatic signs of opiate withdrawal. Neuron 53: 577\u2013589.","journal-title":"Neuron"},{"key":"BFnpp20088_CR38","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1523\/JNEUROSCI.19-12-05016.1999","volume":"19","author":"J Radulovic","year":"1999","unstructured":"Radulovic J, Ruhmann A, Liepold T, Spiess J (1999). Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 19: 5016\u20135025.","journal-title":"J Neurosci"},{"key":"BFnpp20088_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00213-003-1535-6","volume":"170","author":"VB Risbrough","year":"2003","unstructured":"Risbrough VB, Hauger RL, Pelleymounter MA, Geyer MA (2003). Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl) 170: 178\u2013187.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp20088_CR40","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.1523\/JNEUROSCI.5760-03.2004","volume":"24","author":"VB Risbrough","year":"2004","unstructured":"Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA (2004). Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci 24: 6545\u20136552.","journal-title":"J Neurosci"},{"key":"BFnpp20088_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/305325a0","volume":"305","author":"C Rivier","year":"1983","unstructured":"Rivier C, Vale W (1983). Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305: 325\u2013327.","journal-title":"Nature"},{"key":"BFnpp20088_CR42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1476-5381.1996.tb15691.x","volume":"119","author":"F Ruiz","year":"1996","unstructured":"Ruiz F, Fournie-Zaluski MC, Roques BP, Maldonado R (1996). Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism. Br J Pharmacol 119: 174\u2013182.","journal-title":"Br J Pharmacol"},{"key":"BFnpp20088_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0006-8993(95)00043-P","volume":"675","author":"Z Sarnyai","year":"1995","unstructured":"Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G (1995). Brain corticotropin-releasing factor mediates \u2018anxiety-like\u2019 behavior induced by cocaine withdrawal in rats. Brain Res 675: 89\u201397.","journal-title":"Brain Res"},{"key":"BFnpp20088_CR44","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/BF02532385","volume":"21","author":"G Schulteis","year":"1996","unstructured":"Schulteis G, Koob GF (1996). Reinforcement processes in opiate addiction: a homeostatic model. Neurochem Res 21: 1437\u20131454.","journal-title":"Neurochem Res"},{"key":"BFnpp20088_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","volume":"168","author":"Y Shaham","year":"2003","unstructured":"Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168: 3\u201320.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp20088_CR46","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","volume":"20","author":"GW Smith","year":"1998","unstructured":"Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH et al (1998). Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20: 1093\u20131102.","journal-title":"Neuron"},{"key":"BFnpp20088_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/sj.npp.1300487","volume":"30","author":"L Stinus","year":"2005","unstructured":"Stinus L, Cador M, Zorrilla EP, Koob GF (2005). Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology 30: 90\u201398.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp20088_CR48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/520","volume":"19","author":"P Timpl","year":"1998","unstructured":"Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK et al (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19: 162\u2013166.","journal-title":"Nat Genet"},{"key":"BFnpp20088_CR49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0006-8993(02)02707-5","volume":"943","author":"GR Valdez","year":"2002","unstructured":"Valdez GR, Inoue K, Koob GF, Rivier J, Vale W, Zorrilla EP (2002a). Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res 943: 142\u2013150.","journal-title":"Brain Res"},{"key":"BFnpp20088_CR50","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/j.1530-0277.2002.tb02448.x","volume":"26","author":"GR Valdez","year":"2002","unstructured":"Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP et al (2002b). Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res 26: 1494\u20131501.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp20088_CR51","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/01.ALC.0000128222.29875.40","volume":"28","author":"GR Valdez","year":"2004","unstructured":"Valdez GR, Sabino V, Koob GF (2004). Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. Alcohol Clin Exp Res 28: 865\u2013872.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp20088_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0006-8993(03)02971-8","volume":"980","author":"GR Valdez","year":"2003","unstructured":"Valdez GR, Zorrilla EP, Rivier J, Vale WW, Koob GF (2003). Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res 980: 206\u2013212.","journal-title":"Brain Res"},{"key":"BFnpp20088_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2826.2004.01170.x","volume":"16","author":"M Venihaki","year":"2004","unstructured":"Venihaki M, Sakihara S, Subramanian S, Dikkes P, Weninger SC, Liapakis G et al (2004). Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours. J Neuroendocrinol 16: 411\u2013422.","journal-title":"J Neuroendocrinol"},{"key":"BFnpp20088_CR54","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0006-8993(02)03189-X","volume":"952","author":"EP Zorrilla","year":"2002","unstructured":"Zorrilla EP, Valdez GR, Nozulak J, Koob GF, Markou A (2002). Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res 952: 188\u2013199.","journal-title":"Brain Res"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp20088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp20088","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp20088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:11:17Z","timestamp":1738084277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp20088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,20]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["BFnpp20088"],"URL":"https:\/\/doi.org\/10.1038\/npp.2008.8","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,20]]}}}